Literature DB >> 12176041

DOCK2 mediates T cell receptor-induced activation of Rac2 and IL-2 transcription.

Hiroshi Nishihara1, Masae Maeda, Masumi Tsuda, Yoshinori Makino, Hirofumi Sawa, Kazuo Nagashima, Shinya Tanaka.   

Abstract

DOCK2, a CDM family protein exclusively found in hematopoietic cells, has been shown to play a role in lymphocyte migration by the regulation of actin cytoskeleton. Although DOCK2 has been shown to induce the activation of Rac1, the regulatory mechanism of Rac2, which is a hematopoietic cell-specific small GTPase, is still unknown. In this study, we examined the role of DOCK2 in the activation of Rac2 in hematopoietic cells. DOCK2 was found to associate with the zeta subunit of the CD3 complex of T cell receptors in Jurkat cells and to activate forced expressed Rac2 in 293T cells. In addition, the stable expression of DOCK2 in Jurkat cells exhibited the elevated activity of endogenous Rac2. Furthermore, the transcriptional activity of interleukin-2 (IL-2) was enhanced in DOCK2-expressing Jurkat cells and the dominant negative form of Rac2 suppressed its elevated IL-2 promoter activity. These results suggest that DOCK2 mediates TCR-dependent activation of Rac2, leading to the regulation of IL-2 promoter activity in T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176041     DOI: 10.1016/s0006-291x(02)00931-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Adhesions ring: a structural comparison between podosomes and the immune synapse.

Authors:  Sarah A Wernimont; Christa L Cortesio; William T N Simonson; Anna Huttenlocher
Journal:  Eur J Cell Biol       Date:  2008-03-17       Impact factor: 4.492

2.  T-cell mitochondrial dysfunction and lymphopenia in DOCK2-deficient patients.

Authors:  Mohammed F Alosaimi; Hiba Shendi; Abdallah Beano; Kelsey Stafstrom; Rabab El Hawary; Safa Meshaal; Nermeen Galal; Sung-Yun Pai; Aisha El-Marsafy; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2019-03-01       Impact factor: 10.793

3.  DOCK2 is a microglial specific regulator of central nervous system innate immunity found in normal and Alzheimer's disease brain.

Authors:  Patrick J Cimino; Izabela Sokal; James Leverenz; Yoshinori Fukui; Thomas J Montine
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

4.  Rac activation by the T-cell receptor inhibits T cell migration.

Authors:  Eva Cernuda-Morollón; Jaime Millán; Mark Shipman; Federica M Marelli-Berg; Anne J Ridley
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

Review 5.  MicroRNA Regulation of the Small Rho GTPase Regulators-Complexities and Opportunities in Targeting Cancer Metastasis.

Authors:  Brock A Humphries; Zhishan Wang; Chengfeng Yang
Journal:  Cancers (Basel)       Date:  2020-04-28       Impact factor: 6.639

6.  FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.

Authors:  Min Wu; Li Li; Max Hamaker; Donald Small; Amy S Duffield
Journal:  Haematologica       Date:  2019-04-11       Impact factor: 9.941

7.  Structure analysis between the SWAP-70 RHO-GEF and the newly described PLD2-GEF.

Authors:  Julian Gomez-Cambronero
Journal:  Small GTPases       Date:  2012-08-03

8.  A global transcriptional view of apoptosis in human T-cell activation.

Authors:  Min Wang; Dirk Windgassen; Eleftherios T Papoutsakis
Journal:  BMC Med Genomics       Date:  2008-10-23       Impact factor: 3.063

9.  Monozygotic Twins Concordant for Common Variable Immunodeficiency: Strikingly Similar Clinical and Immune Profile Associated With a Polygenic Burden.

Authors:  Susana L Silva; Mariana Fonseca; Marcelo L M Pereira; Sara P Silva; Rita R Barbosa; Ana Serra-Caetano; Elena Blanco; Pedro Rosmaninho; Martin Pérez-Andrés; Ana Berta Sousa; Alexandre A S F Raposo; Margarida Gama-Carvalho; Rui M M Victorino; Lennart Hammarstrom; Ana E Sousa
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.